Compound ID | 2792
Class: Natural product antibiotic
| Details of activity: | Active against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium paratuberculosis; inhibits protein secretion via Sec translocation (SecY inhibitor) |
| Description: | Natural product from Amycolatopsis sp. discovered form screening fermentation broths of previously uncultured bacteria; shows 50% cytotoxicity to liver and mouse embryonic fibroblast cell lines at 16-32 ug/ml |
| Institute where first reported: | Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA; NovoBiotic Pharmaceuticals, LLC, Cambridge, Massachusetts, USA |
| Year first mentioned: | 2020 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://pubmed.ncbi.nlm.nih.gov/32753498/ |